Skip to main content
SpringerLink
Log in

Quality of Life After Off-Label Thrombolysis for Ischemic Stroke in Elderly Patients

  • Original Research Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Introduction

The use of intravenous thrombolysis with alteplase for ischemic stroke in Europe is restricted to subjects aged <80 years. Recent studies have reported the efficacy and safety of alteplase in older patients. However, data concerning the quality of life (QOL) of these elderly subjects are sparse.

Objectives

The aim of this study was to compare the QOL of patients aged ≥80 years with that of patients aged <80 years at 3 months after thrombolysis.

Method

This was a prospective study comprising French-speaking patients aged >18 years treated using thrombolytic therapy for ischemic stroke at the Hospital of Tours (Tours, France) between June 2012 and January 2013. QOL was assessed using the Stroke Impact Scale (SIS). The presence of mood disorders or cognitive impairments was also assessed.

Results

QOL was evaluated for 62 subjects among the 83 enrolled patients who received thrombolytic treatment; 21 patients were aged >80 years. Concerning scores on the SIS, using a multivariate analysis, only the memory and thinking score was significantly and negatively associated with the elderly population [odds ratio (OR) 0.036, 95 % confidence interval (CI) 0.004–0.339; p = 0.004]. No significant difference was observed among all the other QOL scores. Neurological recovery and functional status did not differ between the two groups.

Conclusion

QOL after intravenous thrombolysis in the elderly population was comparable to that of younger subjects. Despite its small sample size, this study showed promising results in favor of intravenous thrombolysis in the elderly population and highlighted the importance of systematic screening for post-stroke cognitive impairment, particularly in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Feigin VL, Lawes CMM, Bennett DA, et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2:43–53.

    Article  PubMed  Google Scholar 

  2. Béjot Y, Rouaud O, Jacquin A, et al. Stroke in the very old: incidence, risk factors, clinical features, outcomes and access to resources—a 22-year population-based study. Cerebrovasc Dis. 2010;29:111–21.

    Article  PubMed  Google Scholar 

  3. Saposnik G, Cote R, Phillips S, et al. Stroke outcome in those over 80: a multicenter cohort study across Canada. Stroke. 2008;39:2310–7.

    Article  PubMed  Google Scholar 

  4. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581–7.

    Article  Google Scholar 

  5. Berrouschot J, Röther J, Glahn J, et al. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients. Stroke. 2005;36:2421–5.

    Article  CAS  PubMed  Google Scholar 

  6. IST-3 collaborative group, Sandercock P, Wardlaw JM, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke [the third international stroke trial (IST-3)]: a randomised controlled trial. Lancet. 2012;379:2352–63.

    Article  Google Scholar 

  7. IST-3 collaborative group. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes [the third International Stroke Trial (IST-3)]: 18-month follow-up of a randomised controlled trial. Lancet Neurol. 2013;12:768–76.

    Article  Google Scholar 

  8. Kissela B. The value of quality of life research in stroke. Stroke. 2006;37:1958–9.

    Article  PubMed  Google Scholar 

  9. Anderson C. Thrombolysis with alteplase after stroke: extending outcomes. Lancet Neurol. 2013;12:731–2.

    Article  CAS  PubMed  Google Scholar 

  10. Morris JH, van Wijck F, Joice S, et al. Predicting health related quality of life 6 months after stroke: the role of anxiety and upper limb dysfunction. Disabil Rehabil. 2013;35:291–9.

    Article  PubMed  Google Scholar 

  11. Carod-Artal J, Egido JA, González JL, et al. Quality of life among stroke survivors evaluated 1 year after stroke: experience of a stroke unit. Stroke. 2000;31:2995–3000.

    Article  CAS  PubMed  Google Scholar 

  12. Carod-Artal FJ, Egido JA. Quality of life after stroke: the importance of a good recovery. Cerebrovasc Dis. 2009;27(Suppl 1):204–14.

    Article  PubMed  Google Scholar 

  13. Hackett ML, Anderson CS. Predictors of depression after stroke: a systematic review of observational studies. Stroke. 2005;36:2296–301.

    Article  PubMed  Google Scholar 

  14. Dhamoon MS, Moon YP, Paik MC, et al. Quality of life declines after first ischemic stroke. The Northern Manhattan Study. Neurology. 2010;75:328–34.

    CAS  PubMed  Google Scholar 

  15. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.

    Article  CAS  PubMed  Google Scholar 

  16. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768–74.

    Article  PubMed  Google Scholar 

  17. Boulouis G, Dumont F, Cordonnier C, et al. Intravenous thrombolysis for acute cerebral ischaemia in old stroke patients ≥80 years of age. J Neurol. 2012;259:1461–7.

    Article  PubMed  Google Scholar 

  18. Duncan PW, Wallace D, Lai SM, et al. The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke. 1999;30:2131–40.

    Article  CAS  PubMed  Google Scholar 

  19. Carod-Artal FJ, Ferreira Coral L, Stieven Trizotto D, et al. Self- and proxy-report agreement on the Stroke Impact Scale. Stroke. 2009;40:3308–14.

    Article  PubMed  Google Scholar 

  20. Abubakar SA, Isezuo SA. Health related quality of life of stroke survivors: experience of a stroke unit. Int J Biomed Sci. 2012;8:183–7.

    PubMed Central  CAS  PubMed  Google Scholar 

  21. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.

    PubMed  Google Scholar 

  22. Sagen U, Vik TG, Moum T, et al. Screening for anxiety and depression after stroke: comparison of the hospital anxiety and depression scale and the Montgomery and Asberg depression rating scale. J Psychosom Res. 2009;67:325–32.

    Article  PubMed  Google Scholar 

  23. Maier W, Buller R, Philipp M, et al. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988;14:61–8.

    Article  CAS  PubMed  Google Scholar 

  24. Kalafat M, Hugonot-Diener L, Poitrenaud J. Standardisation et étalonnage français du “Mini Mental State”(MMS) version GRECO. Rev Neuropsychol. 2003;13:209–36.

    Google Scholar 

  25. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.

    Article  CAS  PubMed  Google Scholar 

  26. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.

    Article  PubMed  Google Scholar 

  27. Béland R, Lecours AR. The mt-86 β aphasia battery: a subset of normative data in relation to age and level of school education. Aphasiology. 1990;4:439–62.

    Article  Google Scholar 

  28. Mishra NK, Diener H-C, Lyden PD, et al. Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke. 2010;41:2840–8.

    Article  PubMed  Google Scholar 

  29. Mishra NK, Ahmed N, Andersen G, et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ. 2010;341:c6046.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Wardlaw JM, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012;379:2364–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Cenciarelli S, Mazzoli T, Ricci S. Ischaemic stroke and thrombolysis: ask the onset time, not the age! Intern Emerg Med. 2013;8:99–100.

    Article  PubMed  Google Scholar 

  32. Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis in stroke patients of > or = 80 versus <80 years of age–a systematic review across cohort studies. Age Ageing. 2006;35:572–80.

    Article  PubMed  Google Scholar 

  33. Schwab-Malek S, Vatankhah B, Bogdahn U, et al. Depressive symptoms and quality of life after thrombolysis in stroke: the TEMPiS study. J Neurol. 2010;257:1848–54.

    Article  PubMed  Google Scholar 

  34. De Weerd L, Luijckx G-JR, Groenier KH, et al. Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy. BMC Neurol. 2012;12:61.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Murao K, Leys D, Jacquin A, et al. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment. Neurology. 2014;82(23):2048–54.

    Article  CAS  PubMed  Google Scholar 

  36. Carod-Artal FJ, Trizotto DS, Coral LF, et al. Determinants of quality of life in Brazilian stroke survivors. J Neurol Sci. 2009;284:63–8.

    Article  PubMed  Google Scholar 

  37. Jönsson A-C, Lindgren I, Hallström B, et al. Determinants of quality of life in stroke survivors and their informal caregivers. Stroke. 2005;36:803–8.

    Article  PubMed  Google Scholar 

  38. Derex L, Nighoghossian N. Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients. Nat Rev Neurol. 2009;5:506–11.

    Article  PubMed  Google Scholar 

  39. Jiménez Caballero PE, López Espuela F, Portilla Cuenca JC, et al. Charlson comorbidity index in ischemic stroke and intracerebral hemorrhage as predictor of mortality and functional outcome after 6 months. J Stroke Cerebrovasc Dis. 2013;22:e214–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Hôpital Bretonneau, University Hospital of Tours, 2 boulevard Tonnellé, 37000, Tours, France

    Capucine Diard-Detoeuf, Séverine Debiais, Mélanie Imbert, Alexandra Musikas, Marie Gaudron & Bertrand De Toffol

  2. Laboratory of Epidemiology and Public Health, Faculty of Medicine, François Rabelais University, Tours, France

    Emeline Laurent

  3. Department of Geriatrics and Memory Center, University Hospital of Tours, Tours, France

    Caroline Hommet & Karl Mondon

  4. UMR INSERM U930, François Rabelais University, Tours, France

    Caroline Hommet & Karl Mondon

Authors
  1. Capucine Diard-Detoeuf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Séverine Debiais
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mélanie Imbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexandra Musikas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marie Gaudron
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Emeline Laurent
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bertrand De Toffol
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Caroline Hommet
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Karl Mondon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Capucine Diard-Detoeuf.

Ethics declarations

Funding

The authors declare that they received no funding for this study.

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diard-Detoeuf, C., Debiais, S., Imbert, M. et al. Quality of Life After Off-Label Thrombolysis for Ischemic Stroke in Elderly Patients. Drugs Aging 32, 917–926 (2015). https://doi.org/10.1007/s40266-015-0307-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-015-0307-4

Keywords

Search

Navigation